Benefits of Epithelial Repair in COPD by Induced Pluripotent Stem Cells (iPS)

Recruiting N/A Interventional Study
Pulmonary Disease, Chronic Obstructive
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
50 (estimated)
Sponsor
University Hospital, Montpellier · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The aim of this interventional, cross-sectional and pathophysiological experimental study is to evaluate the potential of a patient's induced pluripotent stem (iPS) cells, used prior to the re-differentiation stage, to enable ex vivo repair of the injured epithelium in patients with chronic obstructive pulmonary disease (COPD), smokers without COPD and non-smoking controls. The main questions it …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
General Inclusion Criteria * Male and female participants aged 18 years or older. * Participants with a bronchoscopy indication determined by a pulmonologist (e.g., follow-up exploration, nodule investigation, hemoptysis, cough, sputum production, recurrent bronchitis, or differential diagnosis). …
Contacts

Isabelle VACHIER, PhD

(0)467042020

isabelle.vachier@medbiomed.fr

CONTACT